Safety and Efficacy of Donepezil HCl 23 mg in Patients With Moderate to Severe Alzheimer's Disease
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-label, single-arm, prospective, phase IV trial, evaluating
safety and efficacy of donepezil hydrochloride in patients with moderate to severe
Alzheimer's disease.